Read One Nucleus eNews February 2025 edition
Read February eNews here.
Featuring:
✅ Is Investor Love for the Sector Returning This February? by Tony Jones
Read February eNews here.
Featuring:
✅ Is Investor Love for the Sector Returning This February? by Tony Jones
If you are passionate about the immune system and how it can be targeted to provide therapeutic solutions, enjoy diversity in your research, have a passion for communicating and enjoy working in a collaborative and innovative environment please apply to join our team.
Who we are:
Case Study - by Alicia Gailliez, Business Development Manager
How One Nucleus Helped Deliver a Successful Webinar Series for Domainex
London, February 4, 2025 – Coulter Partners, the global expert in building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Our Future Health and is pleased to announce the placement of Andrew Miles, as Chief Business Officer (CBO).
Are you a business that loves to Innovate? Join us on 27 February from 10.30am as we dive into tax in the Life Sciences Sector, understanding the current R&D tax credits and incentives requirement. Please join us in person (or virtually) for the latest in the series of Life Sciences Catalyst topics, hosted in our Life Sciences Catalyst Business Lounge located in Cambridge.
Come and listen to a panel of Deloitte’s Life Science tax experts for an interactive discussion around the current trends in the world of tax and how they are impacting the industry.
We’re delighted to announce that Samuel Atack will be stepping into the role of Operations Director at Stevenage Bioscience Catalyst on 1st April 2025 when current Operations Director Dave Mudd retires.
If you are passionate about the immune system and how it can be targeted to provide therapeutic solutions, enjoy diversity in your research, have a passion for communicating and enjoy working in a collaborative and innovative environment please apply to join our team.
Who we are: